TuisAVTR • NYSE
add
Avantor Inc
Vorige sluiting
$9,06
Dagwisseling
$9,00 - $9,28
Jaarwisseling
$8,90 - $18,02
Markkapitalisasie
6,25 mjd USD
Gemiddelde volume
14,03 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NYSE
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Des. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 1,66 mjd | -1,36% |
Bedryfskoste | 354,70 m | 23,93% |
Netto inkomste | 52,40 m | -89,53% |
Netto winsgrens | 3,15 | -89,38% |
Wins per aandeel | 0,22 | -18,52% |
EBITDA | 272,50 m | -27,83% |
Effektiewe belastingkoers | 35,15% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Des. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 365,40 m | 39,36% |
Totale bates | 11,79 mjd | -2,64% |
Totale aanspreeklikheid | 6,23 mjd | 1,17% |
Totale ekwiteit | 5,56 mjd | — |
Uitstaande aandele | 682,06 m | — |
Prys om te bespreek | 1,10 | — |
Opbrengs op bates | 3,60% | — |
Opbrengs op kapitaal | 4,42% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Des. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 52,40 m | -89,53% |
Kontant van bedrywe | 152,70 m | -11,89% |
Kontant van beleggings | -39,70 m | -107,11% |
Kontant van finansiering | 700,00 k | 100,09% |
Netto kontantverandering | 113,60 m | 349,12% |
Beskikbare kontantvloei | 90,78 m | -71,07% |
Meer oor
Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”. Wikipedia
Gestig
1904
Webwerf
Werknemers
13 500
